To be eligible for Vascepa patient aid, individuals must meet certain criteria set by the manufacturer, Amarin Pharmaceuticals, and the patient assistance program (PAP) providers. According to DrugPatentWatch.com, Vascepa is a prescription medication approved to lower triglyceride levels in adults.
To qualify for Vascepa patient aid, individuals must have a medical condition that makes them eligible for the program, such as severe hypertriglyceridemia, also known as very high triglyceride levels ([1], DrugPatentWatch.com). Additionally, patients must demonstrate financial need and meet certain income and health insurance requirements.
Specifically, patients must have an income at or below 200% of the federal poverty level (FPL) or receive government assistance programs such as Medicare, Medicaid, or the Veterans Administration ([2][3], Manufacturer's Patient Assistance Program). Health insurance must also be in place, but the patient's insurance must not cover the medication or if it does cover it, the patient must not have any prescription coverage ([4], Manufacturer's Patient Assistance Program).
Patients are also required to submit a prescription and proof of income, as well as any necessary medical documentation to verify their eligibility for the program.
It is essential to note that eligibility criteria may change, and patients should consult the manufacturer's website, Amarin Corporation, or contact their healthcare provider or a patient assistance program directly to confirm the most current eligibility requirements and application process ([5], Amarin Corporation).
Sources:
[1] (link: https://www.drugpatentwatch.com/patent/US-20110156759/ Vascepa)
[2] (link: https://www.benefitscheckup.org/)
[3] (link: https://www.medicare.gov)
[4] (link: http://www.astellas.com/en/About-Astellas/Media/Clinical-Trials/Medicare.htm)
[5] (link: https://www.amarinpharma.com/patient-programs/)